Johns Hopkins is currently seeking participants for a phase II clinical trial for treating patients with advanced breast cancer with azacitidine and entinostat. Several sites are participating in the US, Australia, China and Singapore. Be sure to click the link to learn more and share with your oncology team.
© 2004–2011 Donna Peach. All rights reserved.